Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects
Clinical Trial Grant
Awarded By
Boehringer Ingelheim Corporation
Start Date
April 4, 2019
End Date
July 30, 2020
Awarded By
Boehringer Ingelheim Corporation
Start Date
April 4, 2019
End Date
July 30, 2020